Frank D. Heuszel is CEO at IMPACT BIOMEDICAL INC. (IBO). They have made 3 open-market trades across 1 company since 2024, most recently 2024-12-05.
CIK 0001748704
3 open-market purchases totalling $5K since 2024, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.